Chromosomal aberrations in lymphocytes predict human cancer: A report from the European study group on cytogenetic biomarkers and health (ESCH)

Lars Hagmar, Stefano Bonassi, Ulf Strömberg, Anton Brøgger, Lisbeth E. Knudsen, Hannu Norppa, Christina Reuterwall, Alessandra Forni, Inger Lise Hanstcen, Benkt Hogstedt, Alicia Huici Montagud, Bo Lambert, Felix Mitelman, Ingrid Nordenson, Sisko Salomaa, Staffan Skerfving

Research output: Contribution to journalArticle

Abstract

Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and micronuclei (MN) in peripheral blood lymphocytes have for decades been used as cytogenetic biomarkers to survey genotoxic risks in the work environment. The conceptual basis for this application has been the idea that increased cytogenetic damage reflects an enhanced cancer risk. Nordic and Italian cohorts have been established to evaluate this hypothesis, and analyses presented previously have shown a positive trend between CA frequency and increased cancer risk. We now report on a pooled analysis of updated data for 3541 subjects examined for CAs, 2703 for SCEs, and 1496 for MN. To standardize for interlaboratory variation, the results for the various cytogenetic end points were trichotomized on the basis of the absolute value distribution within each laboratory as 'low' (1-33 percentile), 'medium' (34- 66 percentile), or 'high' (67-100 percentile). In the Nordic cohort, there was an elevated standardized incidence ratio (SMR) for all cancer among subjects with high CA frequency [1.53; 95% confidence interval (CI), 1.13- 2.05] but not for those with medium or low CA frequency. In the Italian cohort, a SMR in cancer of 2.01 (95% CI, 1.35-2.89) was obtained for those with a high CA frequency level, whereas the SMRs for those with medium or low did not noticeably differ from unity. Cox's proportional hazards models gave no evidence that the effect of CAs on total cancer incidence/mortality was modified by gender, age at test, or time since test. No association was seen between the SCEs or the MN frequencies and subsequent cancer incidence/mortality. The present study further supports our previous observation on the cancer predictivity of the CA biomarker, which seems to be independent of age at test, gender, and time since test. The risk patterns were similar within each national cohort. This result suggests that the frequency of CAs in peripheral blood lymphocytes is a relevant biomarker for cancer risk in humans, reflecting either early biological effects of genotoxic carcinogens or individual cancer susceptibility.

Original languageEnglish
Pages (from-to)4117-4121
Number of pages5
JournalCancer Research
Volume58
Issue number18
Publication statusPublished - Sep 15 1998

Fingerprint

Cytogenetics
Chromosome Aberrations
Biomarkers
Lymphocytes
Health
Neoplasms
Sister Chromatid Exchange
Incidence
Confidence Intervals
Mortality
Tumor Biomarkers
Proportional Hazards Models
Carcinogens

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hagmar, L., Bonassi, S., Strömberg, U., Brøgger, A., Knudsen, L. E., Norppa, H., ... Skerfving, S. (1998). Chromosomal aberrations in lymphocytes predict human cancer: A report from the European study group on cytogenetic biomarkers and health (ESCH). Cancer Research, 58(18), 4117-4121.

Chromosomal aberrations in lymphocytes predict human cancer : A report from the European study group on cytogenetic biomarkers and health (ESCH). / Hagmar, Lars; Bonassi, Stefano; Strömberg, Ulf; Brøgger, Anton; Knudsen, Lisbeth E.; Norppa, Hannu; Reuterwall, Christina; Forni, Alessandra; Hanstcen, Inger Lise; Hogstedt, Benkt; Montagud, Alicia Huici; Lambert, Bo; Mitelman, Felix; Nordenson, Ingrid; Salomaa, Sisko; Skerfving, Staffan.

In: Cancer Research, Vol. 58, No. 18, 15.09.1998, p. 4117-4121.

Research output: Contribution to journalArticle

Hagmar, L, Bonassi, S, Strömberg, U, Brøgger, A, Knudsen, LE, Norppa, H, Reuterwall, C, Forni, A, Hanstcen, IL, Hogstedt, B, Montagud, AH, Lambert, B, Mitelman, F, Nordenson, I, Salomaa, S & Skerfving, S 1998, 'Chromosomal aberrations in lymphocytes predict human cancer: A report from the European study group on cytogenetic biomarkers and health (ESCH)', Cancer Research, vol. 58, no. 18, pp. 4117-4121.
Hagmar, Lars ; Bonassi, Stefano ; Strömberg, Ulf ; Brøgger, Anton ; Knudsen, Lisbeth E. ; Norppa, Hannu ; Reuterwall, Christina ; Forni, Alessandra ; Hanstcen, Inger Lise ; Hogstedt, Benkt ; Montagud, Alicia Huici ; Lambert, Bo ; Mitelman, Felix ; Nordenson, Ingrid ; Salomaa, Sisko ; Skerfving, Staffan. / Chromosomal aberrations in lymphocytes predict human cancer : A report from the European study group on cytogenetic biomarkers and health (ESCH). In: Cancer Research. 1998 ; Vol. 58, No. 18. pp. 4117-4121.
@article{cd224bb34081440eba7648f9848b1a91,
title = "Chromosomal aberrations in lymphocytes predict human cancer: A report from the European study group on cytogenetic biomarkers and health (ESCH)",
abstract = "Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and micronuclei (MN) in peripheral blood lymphocytes have for decades been used as cytogenetic biomarkers to survey genotoxic risks in the work environment. The conceptual basis for this application has been the idea that increased cytogenetic damage reflects an enhanced cancer risk. Nordic and Italian cohorts have been established to evaluate this hypothesis, and analyses presented previously have shown a positive trend between CA frequency and increased cancer risk. We now report on a pooled analysis of updated data for 3541 subjects examined for CAs, 2703 for SCEs, and 1496 for MN. To standardize for interlaboratory variation, the results for the various cytogenetic end points were trichotomized on the basis of the absolute value distribution within each laboratory as 'low' (1-33 percentile), 'medium' (34- 66 percentile), or 'high' (67-100 percentile). In the Nordic cohort, there was an elevated standardized incidence ratio (SMR) for all cancer among subjects with high CA frequency [1.53; 95{\%} confidence interval (CI), 1.13- 2.05] but not for those with medium or low CA frequency. In the Italian cohort, a SMR in cancer of 2.01 (95{\%} CI, 1.35-2.89) was obtained for those with a high CA frequency level, whereas the SMRs for those with medium or low did not noticeably differ from unity. Cox's proportional hazards models gave no evidence that the effect of CAs on total cancer incidence/mortality was modified by gender, age at test, or time since test. No association was seen between the SCEs or the MN frequencies and subsequent cancer incidence/mortality. The present study further supports our previous observation on the cancer predictivity of the CA biomarker, which seems to be independent of age at test, gender, and time since test. The risk patterns were similar within each national cohort. This result suggests that the frequency of CAs in peripheral blood lymphocytes is a relevant biomarker for cancer risk in humans, reflecting either early biological effects of genotoxic carcinogens or individual cancer susceptibility.",
author = "Lars Hagmar and Stefano Bonassi and Ulf Str{\"o}mberg and Anton Br{\o}gger and Knudsen, {Lisbeth E.} and Hannu Norppa and Christina Reuterwall and Alessandra Forni and Hanstcen, {Inger Lise} and Benkt Hogstedt and Montagud, {Alicia Huici} and Bo Lambert and Felix Mitelman and Ingrid Nordenson and Sisko Salomaa and Staffan Skerfving",
year = "1998",
month = "9",
day = "15",
language = "English",
volume = "58",
pages = "4117--4121",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Chromosomal aberrations in lymphocytes predict human cancer

T2 - A report from the European study group on cytogenetic biomarkers and health (ESCH)

AU - Hagmar, Lars

AU - Bonassi, Stefano

AU - Strömberg, Ulf

AU - Brøgger, Anton

AU - Knudsen, Lisbeth E.

AU - Norppa, Hannu

AU - Reuterwall, Christina

AU - Forni, Alessandra

AU - Hanstcen, Inger Lise

AU - Hogstedt, Benkt

AU - Montagud, Alicia Huici

AU - Lambert, Bo

AU - Mitelman, Felix

AU - Nordenson, Ingrid

AU - Salomaa, Sisko

AU - Skerfving, Staffan

PY - 1998/9/15

Y1 - 1998/9/15

N2 - Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and micronuclei (MN) in peripheral blood lymphocytes have for decades been used as cytogenetic biomarkers to survey genotoxic risks in the work environment. The conceptual basis for this application has been the idea that increased cytogenetic damage reflects an enhanced cancer risk. Nordic and Italian cohorts have been established to evaluate this hypothesis, and analyses presented previously have shown a positive trend between CA frequency and increased cancer risk. We now report on a pooled analysis of updated data for 3541 subjects examined for CAs, 2703 for SCEs, and 1496 for MN. To standardize for interlaboratory variation, the results for the various cytogenetic end points were trichotomized on the basis of the absolute value distribution within each laboratory as 'low' (1-33 percentile), 'medium' (34- 66 percentile), or 'high' (67-100 percentile). In the Nordic cohort, there was an elevated standardized incidence ratio (SMR) for all cancer among subjects with high CA frequency [1.53; 95% confidence interval (CI), 1.13- 2.05] but not for those with medium or low CA frequency. In the Italian cohort, a SMR in cancer of 2.01 (95% CI, 1.35-2.89) was obtained for those with a high CA frequency level, whereas the SMRs for those with medium or low did not noticeably differ from unity. Cox's proportional hazards models gave no evidence that the effect of CAs on total cancer incidence/mortality was modified by gender, age at test, or time since test. No association was seen between the SCEs or the MN frequencies and subsequent cancer incidence/mortality. The present study further supports our previous observation on the cancer predictivity of the CA biomarker, which seems to be independent of age at test, gender, and time since test. The risk patterns were similar within each national cohort. This result suggests that the frequency of CAs in peripheral blood lymphocytes is a relevant biomarker for cancer risk in humans, reflecting either early biological effects of genotoxic carcinogens or individual cancer susceptibility.

AB - Chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and micronuclei (MN) in peripheral blood lymphocytes have for decades been used as cytogenetic biomarkers to survey genotoxic risks in the work environment. The conceptual basis for this application has been the idea that increased cytogenetic damage reflects an enhanced cancer risk. Nordic and Italian cohorts have been established to evaluate this hypothesis, and analyses presented previously have shown a positive trend between CA frequency and increased cancer risk. We now report on a pooled analysis of updated data for 3541 subjects examined for CAs, 2703 for SCEs, and 1496 for MN. To standardize for interlaboratory variation, the results for the various cytogenetic end points were trichotomized on the basis of the absolute value distribution within each laboratory as 'low' (1-33 percentile), 'medium' (34- 66 percentile), or 'high' (67-100 percentile). In the Nordic cohort, there was an elevated standardized incidence ratio (SMR) for all cancer among subjects with high CA frequency [1.53; 95% confidence interval (CI), 1.13- 2.05] but not for those with medium or low CA frequency. In the Italian cohort, a SMR in cancer of 2.01 (95% CI, 1.35-2.89) was obtained for those with a high CA frequency level, whereas the SMRs for those with medium or low did not noticeably differ from unity. Cox's proportional hazards models gave no evidence that the effect of CAs on total cancer incidence/mortality was modified by gender, age at test, or time since test. No association was seen between the SCEs or the MN frequencies and subsequent cancer incidence/mortality. The present study further supports our previous observation on the cancer predictivity of the CA biomarker, which seems to be independent of age at test, gender, and time since test. The risk patterns were similar within each national cohort. This result suggests that the frequency of CAs in peripheral blood lymphocytes is a relevant biomarker for cancer risk in humans, reflecting either early biological effects of genotoxic carcinogens or individual cancer susceptibility.

UR - http://www.scopus.com/inward/record.url?scp=0032530829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032530829&partnerID=8YFLogxK

M3 - Article

C2 - 9751622

AN - SCOPUS:0032530829

VL - 58

SP - 4117

EP - 4121

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 18

ER -